Seqens, Lenders Reach Comprehensive Financial Restructuring Agreement

Paul, Weiss is advising an ad hoc group of Seqens lenders on the French pharmaceutical company’s comprehensive financial restructuring. Under the agreement, the group’s senior lenders will acquire a majority stake in Seqens, which manufactures pharmaceutical ingredients and develops custom specialty chemicals for numerous industries. The restructuring is expected to close by the end of the year.

The Paul, Weiss team includes capital solutions and restructuring partner Liz Osborne and counsel Patrick Mackenzie; corporate partners Stefan Arnold-Soulby and Hein Visser, and counsel Lucy Jenkins; antitrust partner Nicole Kar; and tax partner Rohit Pisal and counsel Richard Liu.